Biological and Pharmaceutical Bulletin
Online ISSN : 1347-5215
Print ISSN : 0918-6158
ISSN-L : 0918-6158

This article has now been updated. Please use the final version.

Effects of combined treatment with branched-chain amino acids, citric acid, L-carnitine, coenzyme Q10, zinc, and various vitamins in tumor-bearing mice
Hiroko AwaAkihiko Futamura Takashi HigashiguchiAkihiro ItoNaoharu MoriMiyo MuraiHiroshi OharaTakeshi ChiharaTakaaki Kaneko
Author information
JOURNAL FREE ACCESS Advance online publication

Article ID: b16-00638

Details
Abstract

A functional dietary supplement (FDS) containing Coenzyme Q10, Branched-chain Amino Acids and L-carnitine was administered to tumor-bearing mice, investigating its effects on tumor and muscle tissues. Experiment (A): B16 melanoma cells were implanted subcutaneously into the right side of the abdomen of 8- to 9-week-old C57BL/6J mice. The mice were divided into two groups: a FDS group that received oral administration of FDS (n=10), and a control group that received oral administration of glucose (n=10).The moribund condition was used as the endpoint, and median survival time was determined. Experiment (B): On day 21 after tumor implantation, tumors, soleus muscle, gastrocnemius muscle, and suprahyoid muscles were collected. Tumor and muscle weight and other aspects were evaluated in each group: FDS group (n=15) and control group (n=15). The median survival time was comparable (21 days in the FDS group vs. 18 days in the control group, p=0.30). However, cumulative food intake was significantly higher in the FDS group than the control group (p=0.011). Metastasis of melanoma to the lung was observed in the control group but not in the FDS group (p=0.043). The weight of the suprahyoid muscles was significantly higher in the FDS group than in the control group (p=0.0045). The weight of the tumor was significantly lower in the FDS group than in the control group (p=0.013). The results possibly suggest oral administration of FDS in tumor-bearing mice enhances the maintenance of suprahyoid muscle mass, resulting in an extended feeding period and suppression of tumor growth and metastasis.

Content from these authors
© 2017 The Pharmaceutical Society of Japan
feedback
Top